相似文献/References:
[1]尚思慧,林琬君.左炔诺孕酮宫内缓释系统的非避孕应用[J].中国计划生育和妇产科,2011,(06):0.
SHANG Si-hui,LIN Wan-jun.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(03):0.
[2]柴明涵,董白桦.左炔诺孕酮宫内缓释系统的临床应用[J].中国计划生育和妇产科,2014,(03):0.
[3]宋芷霜,郭宝芝,刘爱珍,等.左炔诺孕酮宫内缓释系统预防子宫内膜息肉复发的临床观察[J].中国计划生育和妇产科,2015,(02):0.
SONG Zhi-shuang,GUO Bao-zhi,LIU Ai-zhen,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2015,(03):0.
[4]程金花,孙德蓉,周芳,等.宫腔镜下电切术联合左炔诺孕酮宫内缓释系统治疗子宫肌瘤的效果观察[J].中国计划生育和妇产科,2015,(05):0.
CHENG Jin-hua,SUN De-rong,ZHOU Fang,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2015,(03):0.
[5]郭清,徐锋,丁珍珍,等.高强度聚焦超声治疗子宫腺肌病3种方案的疗效对比研究[J].中国计划生育和妇产科,2016,(09):0.
GUO Qing,XU Feng,DING Zhen-zhen,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2016,(03):0.
[6]于丽霞,徐琳瑛.高强度聚焦超声联合左炔诺孕酮宫内缓释系统对子宫腺肌病患者血清CA 125、抗子宫内膜抗体、血红蛋白及卵巢功能的影响[J].中国计划生育和妇产科,2019,(4):33.
YU Li-xia,XU LIN-ying*.Effect of high intensity focused ultrasound combined with levonorgestrel releasing intrauterine system on serum CA 125, EMAb, hemoglobin and ovarian function in patients with adenomyosis[J].Chinese Journal of Family Planning & Gynecotokology,2019,(03):33.
[7]韦佳佳,李晶晶*,陈赛琼,等.依托孕烯植入剂与左炔诺孕酮宫内缓释系统的
非避孕益处比较[J].中国计划生育和妇产科,2019,(10):71.
WEI Jia-jia,LI Jing-jing*,CHEN Sai-qiong,et al.Comparing the non-contraceptive benefits of Implanon and LNG-IUS[J].Chinese Journal of Family Planning & Gynecotokology,2019,(03):71.